Home › Non-Small Cell Lung Cancer › Montana › Great Falls
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Great Falls, MT
9 pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Great Falls (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Nagre-recruitPhase 3
- Benefis Sletten Cancer Institute, Great Falls
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- Benefis Sletten Cancer Institute, Great Falls
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Nagre-recruitPhase 3
- Benefis Sletten Cancer Institute, Great Falls
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Nagre-recruitPhase 2
- Benefis Sletten Cancer Institute, Great Falls
- Great Falls Clinic, Great Falls
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Benefis Sletten Cancer Institute, Great Falls
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Benefis Sletten Cancer Institute, Great Falls
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2/3
- Benefis Sletten Cancer Institute, Great Falls
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Benefis Sletten Cancer Institute, Great Falls
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Nagre-recruitObservasyonal na pag-aaral
- Benefis Sletten Cancer Institute, Great Falls
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa Great Falls
- Kanser sa Prostate10 pag-aaral
- Kanser sa Baga9 pag-aaral
- Acute Myeloid Leukemia6 pag-aaral
- Kanser sa Pantog5 pag-aaral
- Kanser sa Suso5 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg5 pag-aaral
- Colorectal Cancer5 pag-aaral
- Melanoma5 pag-aaral
- Colon Cancer4 pag-aaral
- Kanser ng Endometrium3 pag-aaral
- Rectal Cancer3 pag-aaral
- Chronic Lymphocytic Leukemia3 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.